Correlation of genotypes for thiopurine methyltransferase and inosine triphosphate pyrophosphatase with long-term clinical outcomes in Korean patients with inflammatory bowel diseases during treatment with thiopurine drugs

Yoon Suk Jung, Jae Hee Cheon, Jae Jun Park, Chang Mo Moon, Eun Soo Kim, Jin Ha Lee, Seung Won Kim, Jae Hak Kim, Sung Pil Hong, Tae Il Kim, Won Ho Kim

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

There is a lack of research describing the associations between thiopurine methyltransferase (TPMT)/inosine triphosphate pyrophosphatase (ITPA) genotypes and long-term clinical outcomes. We investigated whether TPMT/ITPA genotypes predicted long-term clinical response in Korean patients with inflammatory bowel diseases (IBDs) undergoing thiopurine treatment. A total of 204 patients with IBD in whom thiopurine treatment was indicated were enrolled and categorized by TPMT and ITPA genotypes. Long-term follow-up clinical data for these patients were analyzed with specific focus on disease relapse. Of the 204 patients, 162 (79.4%) patients using thiopurines achieved remission and were included in an analysis of long-term clinical outcomes. There were no significant differences in disease relapse-free survival between wild and mutant types of TPMT (P=0.903) or ITPA (P=0.392), according to the results of the log-rank analysis. Our study suggests that TPMT and ITPA genotypes may not affect the rates of disease relapse in IBD patients treated with thiopurines. Further studies are indicated to confirm the utility of TPMT/ITPA genotyping to guide clinicians formulating individualized treatments for IBD patients requiring thiopurine therapy.

Original languageEnglish
Pages (from-to)121-123
Number of pages3
JournalJournal of human genetics
Volume55
Issue number2
DOIs
Publication statusPublished - 2010 Feb 1

Fingerprint

thiopurine methyltransferase
Pyrophosphatases
Inosine Triphosphate
Inflammatory Bowel Diseases
Genotype
Pharmaceutical Preparations
Recurrence
Therapeutics
Disease-Free Survival

All Science Journal Classification (ASJC) codes

  • Genetics
  • Genetics(clinical)

Cite this

Jung, Yoon Suk ; Cheon, Jae Hee ; Park, Jae Jun ; Moon, Chang Mo ; Kim, Eun Soo ; Lee, Jin Ha ; Kim, Seung Won ; Kim, Jae Hak ; Hong, Sung Pil ; Kim, Tae Il ; Kim, Won Ho. / Correlation of genotypes for thiopurine methyltransferase and inosine triphosphate pyrophosphatase with long-term clinical outcomes in Korean patients with inflammatory bowel diseases during treatment with thiopurine drugs. In: Journal of human genetics. 2010 ; Vol. 55, No. 2. pp. 121-123.
@article{2f1cc0f1046c4af18b2d342503aa2080,
title = "Correlation of genotypes for thiopurine methyltransferase and inosine triphosphate pyrophosphatase with long-term clinical outcomes in Korean patients with inflammatory bowel diseases during treatment with thiopurine drugs",
abstract = "There is a lack of research describing the associations between thiopurine methyltransferase (TPMT)/inosine triphosphate pyrophosphatase (ITPA) genotypes and long-term clinical outcomes. We investigated whether TPMT/ITPA genotypes predicted long-term clinical response in Korean patients with inflammatory bowel diseases (IBDs) undergoing thiopurine treatment. A total of 204 patients with IBD in whom thiopurine treatment was indicated were enrolled and categorized by TPMT and ITPA genotypes. Long-term follow-up clinical data for these patients were analyzed with specific focus on disease relapse. Of the 204 patients, 162 (79.4{\%}) patients using thiopurines achieved remission and were included in an analysis of long-term clinical outcomes. There were no significant differences in disease relapse-free survival between wild and mutant types of TPMT (P=0.903) or ITPA (P=0.392), according to the results of the log-rank analysis. Our study suggests that TPMT and ITPA genotypes may not affect the rates of disease relapse in IBD patients treated with thiopurines. Further studies are indicated to confirm the utility of TPMT/ITPA genotyping to guide clinicians formulating individualized treatments for IBD patients requiring thiopurine therapy.",
author = "Jung, {Yoon Suk} and Cheon, {Jae Hee} and Park, {Jae Jun} and Moon, {Chang Mo} and Kim, {Eun Soo} and Lee, {Jin Ha} and Kim, {Seung Won} and Kim, {Jae Hak} and Hong, {Sung Pil} and Kim, {Tae Il} and Kim, {Won Ho}",
year = "2010",
month = "2",
day = "1",
doi = "10.1038/jhg.2009.125",
language = "English",
volume = "55",
pages = "121--123",
journal = "Journal of Human Genetics",
issn = "1434-5161",
publisher = "Nature Publishing Group",
number = "2",

}

Correlation of genotypes for thiopurine methyltransferase and inosine triphosphate pyrophosphatase with long-term clinical outcomes in Korean patients with inflammatory bowel diseases during treatment with thiopurine drugs. / Jung, Yoon Suk; Cheon, Jae Hee; Park, Jae Jun; Moon, Chang Mo; Kim, Eun Soo; Lee, Jin Ha; Kim, Seung Won; Kim, Jae Hak; Hong, Sung Pil; Kim, Tae Il; Kim, Won Ho.

In: Journal of human genetics, Vol. 55, No. 2, 01.02.2010, p. 121-123.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Correlation of genotypes for thiopurine methyltransferase and inosine triphosphate pyrophosphatase with long-term clinical outcomes in Korean patients with inflammatory bowel diseases during treatment with thiopurine drugs

AU - Jung, Yoon Suk

AU - Cheon, Jae Hee

AU - Park, Jae Jun

AU - Moon, Chang Mo

AU - Kim, Eun Soo

AU - Lee, Jin Ha

AU - Kim, Seung Won

AU - Kim, Jae Hak

AU - Hong, Sung Pil

AU - Kim, Tae Il

AU - Kim, Won Ho

PY - 2010/2/1

Y1 - 2010/2/1

N2 - There is a lack of research describing the associations between thiopurine methyltransferase (TPMT)/inosine triphosphate pyrophosphatase (ITPA) genotypes and long-term clinical outcomes. We investigated whether TPMT/ITPA genotypes predicted long-term clinical response in Korean patients with inflammatory bowel diseases (IBDs) undergoing thiopurine treatment. A total of 204 patients with IBD in whom thiopurine treatment was indicated were enrolled and categorized by TPMT and ITPA genotypes. Long-term follow-up clinical data for these patients were analyzed with specific focus on disease relapse. Of the 204 patients, 162 (79.4%) patients using thiopurines achieved remission and were included in an analysis of long-term clinical outcomes. There were no significant differences in disease relapse-free survival between wild and mutant types of TPMT (P=0.903) or ITPA (P=0.392), according to the results of the log-rank analysis. Our study suggests that TPMT and ITPA genotypes may not affect the rates of disease relapse in IBD patients treated with thiopurines. Further studies are indicated to confirm the utility of TPMT/ITPA genotyping to guide clinicians formulating individualized treatments for IBD patients requiring thiopurine therapy.

AB - There is a lack of research describing the associations between thiopurine methyltransferase (TPMT)/inosine triphosphate pyrophosphatase (ITPA) genotypes and long-term clinical outcomes. We investigated whether TPMT/ITPA genotypes predicted long-term clinical response in Korean patients with inflammatory bowel diseases (IBDs) undergoing thiopurine treatment. A total of 204 patients with IBD in whom thiopurine treatment was indicated were enrolled and categorized by TPMT and ITPA genotypes. Long-term follow-up clinical data for these patients were analyzed with specific focus on disease relapse. Of the 204 patients, 162 (79.4%) patients using thiopurines achieved remission and were included in an analysis of long-term clinical outcomes. There were no significant differences in disease relapse-free survival between wild and mutant types of TPMT (P=0.903) or ITPA (P=0.392), according to the results of the log-rank analysis. Our study suggests that TPMT and ITPA genotypes may not affect the rates of disease relapse in IBD patients treated with thiopurines. Further studies are indicated to confirm the utility of TPMT/ITPA genotyping to guide clinicians formulating individualized treatments for IBD patients requiring thiopurine therapy.

UR - http://www.scopus.com/inward/record.url?scp=77649144586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649144586&partnerID=8YFLogxK

U2 - 10.1038/jhg.2009.125

DO - 10.1038/jhg.2009.125

M3 - Article

C2 - 19960028

AN - SCOPUS:77649144586

VL - 55

SP - 121

EP - 123

JO - Journal of Human Genetics

JF - Journal of Human Genetics

SN - 1434-5161

IS - 2

ER -